Anticoagulation for the Acute Management of Ischemic Stroke

Few prospective studies support the use of anticoagulation during the acute phase of ischemic stroke, though observational data suggest a role in certain populations. Depending on the mechanism of stroke, systemic anticoagulation may prevent recurrent cerebral infarction, but concomitantly carries a...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Austin A., Ikuta, Kevin, Soverow, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031793/
https://www.ncbi.nlm.nih.gov/pubmed/24910565
_version_ 1782317559257759744
author Robinson, Austin A.
Ikuta, Kevin
Soverow, Jonathan
author_facet Robinson, Austin A.
Ikuta, Kevin
Soverow, Jonathan
author_sort Robinson, Austin A.
collection PubMed
description Few prospective studies support the use of anticoagulation during the acute phase of ischemic stroke, though observational data suggest a role in certain populations. Depending on the mechanism of stroke, systemic anticoagulation may prevent recurrent cerebral infarction, but concomitantly carries a risk of hemorrhagic transformation. In this article, we describe a case where anticoagulation shows promise for ischemic stroke and review the evidence that has discredited its use in some circumstances while showing its potential in others.
format Online
Article
Text
id pubmed-4031793
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher YJBM
record_format MEDLINE/PubMed
spelling pubmed-40317932014-06-06 Anticoagulation for the Acute Management of Ischemic Stroke Robinson, Austin A. Ikuta, Kevin Soverow, Jonathan Yale J Biol Med Review Few prospective studies support the use of anticoagulation during the acute phase of ischemic stroke, though observational data suggest a role in certain populations. Depending on the mechanism of stroke, systemic anticoagulation may prevent recurrent cerebral infarction, but concomitantly carries a risk of hemorrhagic transformation. In this article, we describe a case where anticoagulation shows promise for ischemic stroke and review the evidence that has discredited its use in some circumstances while showing its potential in others. YJBM 2014-06-06 /pmc/articles/PMC4031793/ /pubmed/24910565 Text en Copyright ©2014, Yale Journal of Biology and Medicine https://creativecommons.org/licenses/by-nc/3.0/This is an open access article distributed under the terms of the Creative Commons CC BY-NC license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use the material for commercial purposes.
spellingShingle Review
Robinson, Austin A.
Ikuta, Kevin
Soverow, Jonathan
Anticoagulation for the Acute Management of Ischemic Stroke
title Anticoagulation for the Acute Management of Ischemic Stroke
title_full Anticoagulation for the Acute Management of Ischemic Stroke
title_fullStr Anticoagulation for the Acute Management of Ischemic Stroke
title_full_unstemmed Anticoagulation for the Acute Management of Ischemic Stroke
title_short Anticoagulation for the Acute Management of Ischemic Stroke
title_sort anticoagulation for the acute management of ischemic stroke
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031793/
https://www.ncbi.nlm.nih.gov/pubmed/24910565
work_keys_str_mv AT robinsonaustina anticoagulationfortheacutemanagementofischemicstroke
AT ikutakevin anticoagulationfortheacutemanagementofischemicstroke
AT soverowjonathan anticoagulationfortheacutemanagementofischemicstroke

Ejemplares similares